valerates has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Morocutti, C; Piccinin, GL; Urciuoli, R | 1 |
| Marsden, CD; Parkes, JD; Price, PA | 1 |
| Gabreëls, FJ; Schobben, F; van der Kleijn, E | 1 |
1 trial(s) available for valerates and Parkinson Disease
| Article | Year |
|---|---|
Sodium valproate in the treatment of levodopa-induced dyskinesia.
Topics: Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valerates; Valproic Acid | 1978 |
2 other study(ies) available for valerates and Parkinson Disease
| Article | Year |
|---|---|
[The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note].
Topics: Aged; Female; Humans; Male; Middle Aged; Parkinson Disease; Valerates; Valproic Acid | 1977 |
Pharmacokinetics of di-n-propylacetate in epileptic patients.
Topics: Administration, Oral; Aged; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epilepsy; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Models, Biological; Parkinson Disease; Phenobarbital; Valerates; Valproic Acid | 1975 |